We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DuPont Expands Sugar Separation Expertise With New Digital Tool
Read MoreHide Full Article
Key Takeaways
DuPont launched a digital tool to help sugar and sweetener makers evaluate chromatographic separation options.
The Sugar Separation Advisor predicts chromatograms and suggests AmberLite resins for further testing.
DuPont raised its 2026 guidance after Q2 outperformance, citing stronger EBITDA and adjusted earnings.
DuPont de Nemours, Inc.(DD - Free Report) is strengthening its position in the specialty chemicals market with the launch of the DuPont Sugar Separation Advisor, an interactive digital tool designed to help sugar and sweetener manufacturers evaluate chromatographic separation opportunities and identify suitable DuPont AmberLite resins for further testing.
DuPont, which is among the prominent players in the chemical space alongside Dow Inc. (DOW - Free Report) , Eastman Chemical Company (EMN - Free Report) and Celanese Corporation (CE - Free Report) , is focusing on innovation, productivity and growth across healthcare, water and industrial markets. The company's latest digital initiative expands access to its chromatography expertise and experimental separation data, while its broader portfolio includes solutions for healthcare, industrial water, food and beverage and other industrial applications.
The DuPont Sugar Separation Advisor builds on decades of chromatography application expertise and years of experimental separation data. The tool enables users to select a target sugar or sweetener, add up to four additional sugars or impurities to represent their feed stream and generate a predicted chromatogram based on experimental separation data. It then provides a qualitative separation assessment and suggests candidate DuPont AmberLite chromatography resins for further evaluation.
According to DuPont, the platform is designed to simplify the early stages of separation evaluation by helping customers identify promising resin options and focus laboratory testing. This could support manufacturers evaluating applications ranging from high-fructose corn syrup and beet sugar processing to rare sugars, oligosaccharides, polysaccharides and sugar alcohols.
DuPont developed the tool in response to recurring customer questions involving sugars and sweeteners such as allulose, tagatose, sorbitol, oligosaccharides, xylose and inositol. The resource displays laboratory-generated separation data for relevant sugar and resin combinations, helping users assess resin performance in application-relevant scenarios.
DuPont, in August, raised the midpoint of its full-year 2026 operating EBITDA and adjusted earnings guidance following its second-quarter outperformance. The company now expects net sales of $7.16-$7.19 billion, operating EBITDA of $1.75-$1.77 billion and adjusted earnings of $7.17-$7.32 per share. For the second half of 2026, DD projects net sales of $3.66-$3.69 billion, operating EBITDA of $890-$910 million and adjusted earnings of $3.65-$3.80 per share.
Dow expects approximately $200 million in additional benefits from its Transform to Outperform program in 2026, taking total in-year benefits from self-help initiatives to more than $1.3 billion. In the second half, the company plans to focus on growth and innovation in attractive end markets, portfolio investments and balanced capital allocation. DOW expects productivity and growth benefits from the program to accelerate through the remainder of 2026 and into 2027.
EastmanChemical expects 2026 earnings to improve significantly from 2025. Operating cash flow is projected to approach $900 million. For the third quarter, adjusted earnings are expected to be near the second-quarter level of $1.97 per share. Advanced Materials is expected to benefit from improved price-cost dynamics and asset utilization, while Fibers should gain from higher acetate tow purchases.
Celanese expects third-quarter adjusted earnings of $1.35-$1.75 per share and continues to project 2026 adjusted earnings of approximately $6 per share. The company maintained its full-year free cash flow guidance of $700-$800 million. Growth initiatives, productivity measures and portfolio and footprint actions are expected to support 2026 performance and strengthen cash generation.
View the Zacks #1 Rank List
Image: Bigstock
DuPont Expands Sugar Separation Expertise With New Digital Tool
Key Takeaways
DuPont de Nemours, Inc.(DD - Free Report) is strengthening its position in the specialty chemicals market with the launch of the DuPont Sugar Separation Advisor, an interactive digital tool designed to help sugar and sweetener manufacturers evaluate chromatographic separation opportunities and identify suitable DuPont AmberLite resins for further testing.
DuPont, which is among the prominent players in the chemical space alongside Dow Inc. (DOW - Free Report) , Eastman Chemical Company (EMN - Free Report) and Celanese Corporation (CE - Free Report) , is focusing on innovation, productivity and growth across healthcare, water and industrial markets. The company's latest digital initiative expands access to its chromatography expertise and experimental separation data, while its broader portfolio includes solutions for healthcare, industrial water, food and beverage and other industrial applications.
The DuPont Sugar Separation Advisor builds on decades of chromatography application expertise and years of experimental separation data. The tool enables users to select a target sugar or sweetener, add up to four additional sugars or impurities to represent their feed stream and generate a predicted chromatogram based on experimental separation data. It then provides a qualitative separation assessment and suggests candidate DuPont AmberLite chromatography resins for further evaluation.
According to DuPont, the platform is designed to simplify the early stages of separation evaluation by helping customers identify promising resin options and focus laboratory testing. This could support manufacturers evaluating applications ranging from high-fructose corn syrup and beet sugar processing to rare sugars, oligosaccharides, polysaccharides and sugar alcohols.
DuPont developed the tool in response to recurring customer questions involving sugars and sweeteners such as allulose, tagatose, sorbitol, oligosaccharides, xylose and inositol. The resource displays laboratory-generated separation data for relevant sugar and resin combinations, helping users assess resin performance in application-relevant scenarios.
DuPont, in August, raised the midpoint of its full-year 2026 operating EBITDA and adjusted earnings guidance following its second-quarter outperformance. The company now expects net sales of $7.16-$7.19 billion, operating EBITDA of $1.75-$1.77 billion and adjusted earnings of $7.17-$7.32 per share. For the second half of 2026, DD projects net sales of $3.66-$3.69 billion, operating EBITDA of $890-$910 million and adjusted earnings of $3.65-$3.80 per share.
Dow expects approximately $200 million in additional benefits from its Transform to Outperform program in 2026, taking total in-year benefits from self-help initiatives to more than $1.3 billion. In the second half, the company plans to focus on growth and innovation in attractive end markets, portfolio investments and balanced capital allocation. DOW expects productivity and growth benefits from the program to accelerate through the remainder of 2026 and into 2027.
EastmanChemical expects 2026 earnings to improve significantly from 2025. Operating cash flow is projected to approach $900 million. For the third quarter, adjusted earnings are expected to be near the second-quarter level of $1.97 per share. Advanced Materials is expected to benefit from improved price-cost dynamics and asset utilization, while Fibers should gain from higher acetate tow purchases.
Celanese expects third-quarter adjusted earnings of $1.35-$1.75 per share and continues to project 2026 adjusted earnings of approximately $6 per share. The company maintained its full-year free cash flow guidance of $700-$800 million. Growth initiatives, productivity measures and portfolio and footprint actions are expected to support 2026 performance and strengthen cash generation.